SUMMARY The bronchodilator activity of nebulised salbutamol, ipratropium bromide, clemastine, and a placebo was studied in 14 asthmatic children aged between 3 and 5 years. Changes in lung function were monitored by measuring peak expiratory flow rate and total respiratory resistance using a modification of the forced oscillation technique. Ipratropium bromide produced a degree of bronchodilatation similar to that of salbutamol, but the bronchodilator activity of clemastine was not appreciably better than for the placebo.
Salbutamol inhaled from a nebuliser is an effective bronchodilator in children with asthma over age 18 months.' Nevertheless, some asthmatic children continue to have severe symptoms despite nebulised treatment at home, and acute severe asthma remains a common indication for admission to hospital. For these reasons it is justified to investigate the therapeutic effects of other forms of treatment.
It has been shown that an antihistamine, chlorpheniramine, is an effective bronchodilator if inhaled by asthmatic schoolchildren but it is too irritant for general clinical use.2 An alternative antihistamine, clemastine, appears to be superior from this point of view but has not been evaluated in childhood asthma. 3 Anticholinergic drugs are effective in older children and adults with asthma but there is no information on their use in the preschool child. A new anticholinergic agent, ipratropium bromide, is now available and is said to be preferable to atropine, because it produces less tachycardia and a smaller reduction in sputum flow. 4 We have therefore compared the bronchodilator properties of inhaled salbutamol, clemastine, and ipratropium bromide in a group of young asthmatic children to find out if these other drugs have a place in the management of preschool asthma.
Patients
Fourteen children (9 boys and 5 girls) aged 3 years 2 months to 5 years 5 months (mean 4 years 1 month) were studied. They had suffered from asthma for between 1 year 4 months and 4 years 9 months (mean 2 years 8 months). Thirteen children were between the 3rd and 97th centiles for height, and one child was just below the 3rd centile for both height and weight.5 Eight children had a family history of asthma and 5 suffered from eczema. The 2 children on whom skin tests had been performed showed multiple positive responses to common antigens. Ten children had required hospital admissions (range 1 to 9), and 8 Bronchodilator effects of clemnstine, ipratropium bromide, and salbutamol in preschool children 343 sine vave flow oscillation is applied to the respiratory system at the resonant frequency, the impedence to the oscillatory flow is due solely to the total respiratory resistance (RT), since at resonance the elastic and inertial components are of equal magnitude and opposite in sign. The apparatus has been described in detail in a previous article.7
Procedure. The children were studied on four occasions, always at the same time of day and generally over a period of not more than 2 weeks. All medication was stopped for at least 12 hours before each test session. On arrival each mother was questioned about the child's recent health, and then the clinical examinations were performed. Baseline measurements of heart rate, PEFR (best of three attempts), and RT were recorded. After resting for 15 minutes all investigations were repeated. The children then inhaled solutions of the drugs from a Pari nebuliser. The drug regimens used were salbutamol 5 mg, clemastine I mg, ipratropium bromide 250 ,ug, or saline placebo. All drugs were made up in 2 ml of saline and the doses used are about equivalent to half of the normal adult dose (Table) . Changes in lung function were assessed serially over 30 minutes, when second inhalations were administered. These second treatments consisted of salbutamol 5 mg in 2 ml of saline, unless the child had already received this drug in which case the placebo was given. Lung function was assessed after a further 10 minutes. All treatments were administered double-blind and in a random order.
Results
Changes in PEFR and RT are shown in Figs 1 No significant side effects were observed after any of the inhalations. All the drugs were almost tasteless and no child coughed. Small increases in heart rate were noted, particularly after the salbutamol inhalation when there was an average rise of 10 beats a minute at 2 minutes. The other inhalations caused rises of up to 5 beats a minute.
Discussion
As seen in previous reports, the response to inhaled salbutamol was striking.1 7 9 The improvement in lung function after the inhalation of ipratropium bromide was equally impressive, although the response was a little slower. This is the first time that anticholinergic drugs have been shown to be effective in relieving bronchoconstriction in children below age 5 years. There was a small additional improvement after the second inhalation (salbutamol). These results suggest that ipratropium bromide may have a role in the management of preschool asthma, either alone or in combination with beta 2 adrenergic stimulants, and this drug certainly warrants further study. Ipratropium is believed to act mainly on the large airways, while beta stimulants relieve bronchoconstriction both in central and peripheral 
